The Procter & Gamble Company (BVMF:PGCO34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 1.97T +3.4% |
| Revenue (ttm) | 455.43B +3.5% |
| Net Income | 81.51B -4.4% |
| EPS | 2.53 -3.1% |
| Shares Out | n/a |
| PE Ratio | 23.85 |
| Forward PE | 21.68 |
| Dividend | 1.06 (1.75%) |
| Ex-Dividend Date | Oct 22, 2026 |
| Volume | 2,677 |
| Open | 60.95 |
| Previous Close | 60.96 |
| Day's Range | 59.86 - 61.38 |
| 52-Week Range | 49.68 - 63.86 |
| Beta | 0.38 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 22, 2026 |
About BVMF:PGCO34
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. ... [Read more]
Financial Performance
In fiscal year 2026, BVMF:PGCO34's revenue was $87.03 billion, an increase of 3.26% compared to the previous year's $84.28 billion. Earnings were $15.75 billion, an increase of 0.45%.
Financial numbers in USD Financial StatementsNews
Procter & Gamble price target raised to $167 from $145 at Piper Sandler
Piper Sandler analyst Michael Lavery raised the firm’s price target on Procter & Gamble to $167 from $145 and keeps a Neutral rating on the shares. While organic top-line momentum…
Procter & Gamble price target raised to $165 from $152 at Barclays
Barclays raised the firm’s price target on Procter & Gamble to $165 from $152 and keeps an Equal Weight rating on the shares. The firm cites the company’s earnings beat…
Procter & Gamble upgraded to Buy from Hold at Freedom Broker
Freedom Broker upgraded Procter & Gamble to Buy from Hold with a price target of $176, up from $164. The firm cites the company’s strong start to fiscal 2027 for…
Procter & Gamble price target raised to $190 from $172 at UBS
UBS raised the firm’s price target on Procter & Gamble to $190 from $172 and keeps a Buy rating on the shares.
Procter & Gamble price target raised to $166 from $150 at TD Cowen
TD Cowen raised the firm’s price target on Procter & Gamble to $166 from $150 and keeps a Hold rating on the shares. The firm updated its model following strong…
Procter & Gamble price target raised to $185 from $170 at BofA
BofA analyst Peter Galbo raised the firm’s price target on Procter & Gamble to $185 from $170 and keeps a Buy rating on the shares. P&G “kicked off FY27 on…
Procter & Gamble price target raised to $176 from $162 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Procter & Gamble to $176 from $162 and keeps a Buy rating on the shares. The company’s stronger than expected fiscal Q1…
Procter & Gamble price target raised to $169 from $166 at RBC Capital
RBC Capital analyst Nik Modi raised the firm’s price target on Procter & Gamble to $169 from $166 and keeps an Outperform rating on the shares. The company reported a…
Procter & Gamble price target raised to $180 from $162 at JPMorgan
JPMorgan raised the firm’s price target on Procter & Gamble to $180 from $162 and keeps an Overweight rating on the shares.
Procter & Gamble price target raised to $187 from $180 at Citi
Citi raised the firm’s price target on Procter & Gamble to $187 from $180 and keeps a Buy rating on the shares. The firm views the company’s fiscal Q1 report…
Procter & Gamble price target raised to $185 from $166 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Procter & Gamble to $185 from $166 and keeps an Overweight rating on the shares. Brand interventions and recent reinvestment have “begun…
Procter & Gamble price target raised to $180 from $164 at Wells Fargo
Wells Fargo raised the firm’s price target on Procter & Gamble to $180 from $164 and keeps an Overweight rating on the shares. The company’s Q1 saw its best organic…
Procter & Gamble price target raised to $161 from $150 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Procter & Gamble to $161 from $150 and keeps a Neutral rating on the shares after its Q1 earnings beat. Heading into…
Procter & Gamble Sees Resilient Consumer Demand Despite Higher Commodity Costs
Consumer packaged goods (CPG) company Procter & Gamble expects the costs of raw materials, energy and transportation to be higher throughout its fiscal year 2027, the firm said in a Thursday (Oct. 22)...
How agentic AI shopping changes consumer staples: P&G CFO
Procter & Gamble Chief Financial Officer Andre Schulten tells Brian Sozzi that the US consumer is remarkably resilient even as it splits in two. The consensus is that AI shopping agents commoditize br...
These 2 dividend stocks are worth owning for a lifetime
A dividend stock earns its place in a long-term portfolio by doing more than mailing shareholders a quarterly check. It needs a business that can fund those payments while investing sufficiently to st...
Procter & Gamble Stock (PG) Is Up 6% and Having Its Best Day in More Than a Year. Here’s Why
The company is managing to attract consumers.
Procter & Gamble says ‘confident’ in sales, EPS guidance for FY27
Says FY27 results won’t be a straight line due to external factors. Says has more time to react to cost pressures in 2H27 vs. Q2. Expects to increase productivity in…
Procter & Gamble says level of productivity increasing
Says has operating leverage on GOGS side. Says if oil stays over $100 barrel, it will represent an “increasing headwind” for the year. Says well equipped to handle cost pressures.
Procter & Gamble Stock (PG) Jumps on Q1 Beat, Braces for $1.4B Hit from Higher Costs
Procter & Gamble shares ($PG) rose 6% to about $166 on Thursday morning. This followed the consumer goods giant’s first-quarter fiscal 2027 earnings, which surpassed Wall Street expectations. However,...
P&G beats estimates - but $1.4B cost squeeze clouds celebration
Procter & Gamble (PG) delivered better-than-expected earnings for its fiscal Q1, offering investors evidence that demand for its household staples can withstand pressure on consumer budgets. The Tide ...
The Procter & Gamble Company Earnings Call Transcript: Q1 2027
Organic sales rose 4.0% with growth across all categories and regions, while core EPS reached $2. FY27 guidance was maintained despite rising cost pressures, with H1 growth expected near 3% and a slight H2 acceleration.
The Procter & Gamble Company Earnings release: Q1 2027
The Procter & Gamble Company released its Q1 2027 earnings on October 22, 2026, summarizing the period's financial results.
The Procter & Gamble Company Slides: Q1 2027
The Procter & Gamble Company has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on October 22, 2026.
The Procter & Gamble Company Quarterly report: Q1 2027
The Procter & Gamble Company has published its Q1 2027 quarterly earnings report on October 22, 2026.